Bone Therapeutics SA (BIOS): key financial figures for fiscal year 2024 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2024)
- €3.1M
- Net Income/Loss (FY2024)
- -€6.7M
- Total Assets (FY2024)
- €4.7M
- Total Equity (FY2024)
- -€26.8M
- Cash Flows from Operating Activities (FY2024)
- -€2.2M
Source: Bone Therapeutics SA annual_report filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
